Hello, Fool! | Login | Signup | My Fool
Nov 19, 2008 10:11 AM ET | Feedback | Site Changes | Help
Engaged in discovery, development, manufacturing and marketing of pharmaceutical products and has two business segments - diabetes care and biopharmaceuticals.
View All Commentary (NVO)
Recs
biovestor (< 20) Submitted: 6/28/08 8:06 AM : Start Price: $65.90 NVO Score: 5.89
An innovative leader in the field of diabetes care, NVO is poised to continue its rapid growth based on the obesity and diabetes epidemic in the USA and other developed countries.
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK